Clinical Trials Directory

Trials / Completed

CompletedNCT05880693

Comparisons Between Dexmedetomidine and Magnesium Sulfate in Controlled Hypotension During Rhinoplasty Surgeries

Dexmedetomidine Versus Magnesium Sulfate in Controlled Hypotension During Rhinoplasty Surgeries

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
56 (actual)
Sponsor
mohamed · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

General anesthesia organizes the best option for controlled blood pressure during rhinoplasty surgery. The primary agent applied in controlling hypotension should have particular unique characteristics. The dexmedetomidine central and peripheral sympatholytic performance is usually indicated by low blood pressure and low heart rate. magnesium sulfate is among the best agents used.

Detailed description

This is a prospective comparative randomized study. 56 patients got enrolled and then divided into two groups. Group 1 received dexmedetomidine (n=28), while the group 2 received magnesium sulfate (n=28). MAP, as well as heart rate, were recorded. Surgeon satisfaction was approximated for the surgical field quality. The amount of blood loss during the entire process was measured. The score of pain was evaluated using the NRS rating scale. Sedation score through Ramsey sedation score. The time required for the first requirement of analgesia was also recorded as well as intraoperative and postoperative problems.

Conditions

Interventions

TypeNameDescription
DRUGDexmedetomidineGroup 1 received dexmedetomidine
DRUGMagnesium sulfatethe group 2 received magnesium sulfate

Timeline

Start date
2022-01-01
Primary completion
2023-04-01
Completion
2023-05-01
First posted
2023-05-30
Last updated
2023-05-31

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05880693. Inclusion in this directory is not an endorsement.